Patent intelligence · US
US 7547546
Progenitor cells from wharton's jelly of human umbilical cord
Progenitor cells from wharton's jelly of human umbilical cord
Patent details — US 7547546
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jun 16, 2009
- Expiration
- Jun 11, 2029
- Applicant
- Tissue Regeneration Therapeutics Inc.
- Claims
- 6
- CPC classes
- A61K, A61K35/51
Quick answer
US 7547546 (Progenitor cells from wharton's jelly of human umbilical cord) is held by Tissue Regeneration Therapeutics Inc.. Status: granted. Granted Jun 16, 2009. Expires Jun 11, 2029 (3 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Tissue Regeneration Therapeutics Inc.
- Grant date
- Expiration
- Claims
- 6
- CPC classes
- A61K, A61K35/51
More from Tissue Regeneration Therapeutics Inc.
Related pharmaceutical patents in our USPTO index.
-
US 12428463
Chimeric antigen receptors targeting abnormal glycobiology
granted -
US 12427148
Cancer treatment targeted to tumor adaptive responses to protein synthesis stress
granted -
US 12428416
ERK inhibitors and uses thereof
granted -
US 12427151
Compositions and method of treating cancer
granted -
US 12427197
Methods of producing cobalt nanoparticles and hollow metal nanospheres
granted -
US 12428489
Human PD-L2 antibodies and methods of use therefor
granted -
US 12427155
Treatment for tau-related diseases
granted -
US 12428455
Dominant negative CEBPB and CEBPD proteins and methods of use for decreasing viability of neoplastic cells
granted
Frequently asked questions
What is US patent 7547546?
US 7547546 (Progenitor cells from wharton's jelly of human umbilical cord) is held by Tissue Regeneration Therapeutics Inc.. Status: granted. Granted Jun 16, 2009. Expires Jun 11, 2029 (3 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 7547546?
Tissue Regeneration Therapeutics Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 8,292 pharmaceutical patents for this assignee.
When does US 7547546 expire?
Our index shows an expiration date of Jun 11, 2029 (3 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.